[Severe combined immunodeficiency].
Okawa
H
H
Department of Pediatrics, Tokyo Medical & Dental University School of Medicine.
D004268:DNA-Binding Proteins / Q000235:genetics; D018398:Homeodomain Proteins / Q000235:genetics; D006801:Humans; D053616:Janus Kinase 3; D009687:Nuclear Proteins; D011379:Prognosis; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D015375:Receptors, Interleukin-2 / Q000235:genetics; D016511:Severe Combined Immunodeficiency / Q000145:classification / Q000209:etiology / Q000235:genetics; D014960:X Chromosome; D051746:ZAP-70 Protein-Tyrosine Kinase
D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; D009687:Nuclear Proteins; C499311:RAG2 protein, human; D011948:Receptors, Antigen, T-Cell; D015375:Receptors, Interleukin-2; C064655:V(D)J recombination activating protein 2; C064658:RAG-1 protein; D011505:Protein-Tyrosine Kinases; C507933:JAK3 protein, human; D053616:Janus Kinase 3; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human